Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebral artery smooth muscle cells (VSMCs) are specialized contractile cells encircling the walls of arteries in the brain. They regulate cerebral blood flow by contracting or relaxing in response to neural, metabolic, and myogenic stimuli, primarily through changes in intracellular calcium and membrane potential. These cells express a diverse set of ion channels (including voltage-gated calcium channels, potassium channels such as BKCa and Kv, and non-selective cation channels of the TRP family), signaling proteins, and contractile elements (such as actins and myosins). Dysfunction of cerebral artery VSMCs contributes to diseases including hypertension, stroke, and cerebrovascular disorders. However, as a cell type rather than a specific molecule, they are not a single druggable "target" [5][1][3][2][6].
Not applicable as a cell type; mechanisms relate to the specific molecular targets expressed by these cells (e.g., calcium channel blockade causing vasodilation).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral artery smooth muscle cell.